These Connecticut-based companies made this year's Fortune 500 list with revenue up to $275 billion
Fifteen Connecticut-headquartered companies made the 2026 Fortune 500, with revenues based on prior fiscal years. Cigna (Bloomfield) led at No. 14 with about $274.9 billion revenue. Amazon ranked No. 1 overall with nearly $717 billion. The Fortune 500 totaled about $21 trillion in revenue and $2 trillion in profits in 2025.

Fortune 500 ranking is a recap, but the article bundles multiple company-specific actions (CEO transition, layoffs, ACA exchange exit, FTC settlement) that can affect near-term sentiment and risk.
Cigna is highlighted as No. 14 in the Fortune 500 with 2025 revenue up ~11%, plus leadership retirement, layoffs, ACA exchange exit, and FTC insulin-PBM settlement details.
Low-to-medium near-term volatility risk; direction unclear without market reaction data.
Background
The article lists Connecticut-headquartered companies in the 2026 Fortune 500 (based on prior fiscal-year revenues) and adds a short rundown of selected recent developments for several firms.
Why it matters
Most of the piece is ranking/recap content, but it includes company-specific items for Cigna (leadership transition, layoffs, ACA exchange exit, FTC insulin-PBM settlement), Charter (merger timing), Synchrony (Q4 purchase volume and charge-offs), and Amphenol (acquisition-driven growth).
Market relevance
Trading relevance is concentrated in the bundled company-specific datapoints (CI regulatory/leadership actions, SYF credit metrics, APH acquisition-driven growth, CHTR merger timing). Pure ranking mentions are likely low incremental impact.
Market effects
Health insurers/PBMs face ongoing regulatory scrutiny (CI FTC insulin-PBM settlement) while telecom and consumer credit narratives (CHTR merger progress; SYF charge-offs) remain sentiment-sensitive.
Connecticut corporate footprint is emphasized; limited direct tradable regional effect beyond sector read-through.
Fortune 500 scale recap with limited incremental global macro signal; only CI/PM strategic/regulatory themes have broader policy relevance.
Alternative perspectives
Treat this primarily as a Fortune 500 recap: most price-relevant catalysts (CI FTC settlement, layoffs, ACA exchange exit, CHTR merger) may already be known, so incremental trading impact could be small.
Market reaction will depend on whether traders already priced the CI regulatory/leadership items and whether SYF’s charge-off trend is better or worse than consensus expectations—neither is provided here.
Key entities
- companyThe Cigna Group
Connecticut-headquartered health insurer/PBM; No. 14 Fortune 500; includes leadership retirement, layoffs, ACA exchange exit, and FTC insulin-PBM settlement details.
- companyCharter Communications
Connecticut-headquartered cable/internet provider; No. 85; expects to complete Cox merger in 2H 2026.
- companySynchrony
Store credit provider; No. 197; includes Q4 2025 purchase volume and net charge-off rate.
- companyAmphenol
Electronic components maker; No. 198; cites acquisition-driven revenue growth.



